{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:20:00Z","timestamp":1757618400556,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00277-025-06460-5","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:31:55Z","timestamp":1749871915000},"page":"3609-3618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Good response to oxymetholone in adult aplastic anemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Jindaratn","family":"Chaipokam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7912-1996","authenticated-orcid":false,"given":"Ponlapat","family":"Rojnuckarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"6460_CR1","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00277-021-04566-0","volume":"100","author":"L Norasetthada","year":"2021","unstructured":"Norasetthada L, Wongkhantee S, Chaipokam J, Charoenprasert K, Chuncharunee S, Rojnuckarin P et al (2021) Adult aplastic anemia in thailand: incidence and treatment outcome from a prospective nationwide population-based study. Ann Hematol 100:2443\u20132452. https:\/\/doi.org\/10.1007\/s00277-021-04566-0","journal-title":"Ann Hematol"},{"key":"6460_CR2","first-page":"405","volume":"30","author":"N Uerprasert","year":"2020","unstructured":"Uerprasert N, Chanthorn-Soong K, Pongthanadul B, Leowahussiriwong S, Sirichainun N, Visuthisakchai S et al (2020) Guidelines for diagnosis and management of aplastic anemia in Thailand 2020. J Hematol Transfus Med 30:405\u2013413. https:\/\/he01.tci-thaijo.org\/index.php\/JHematolTransfusMed\/article\/view\/245537","journal-title":"J Hematol Transfus Med"},{"key":"6460_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","volume":"129","author":"A Bacigalupo","year":"2017","unstructured":"Bacigalupo A (2017) How I treat acquired aplastic anemia. Blood 129:1428\u20131436. https:\/\/doi.org\/10.1182\/blood-2016-08-693481","journal-title":"Blood"},{"key":"6460_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1182\/asheducation-2016.1.83","volume":"2016","author":"DM Townsley","year":"2016","unstructured":"Townsley DM, Winkler T (2016) Nontransplant therapy for bone marrow failure. Hematology Am Soc Hematol Educ Program 2016:83\u201389. https:\/\/doi.org\/10.1182\/asheducation-2016.1.83","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"6460_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1182\/asheducation-2013.1.76","volume":"2013","author":"NS Young","year":"2013","unstructured":"Young NS (2013) Current concepts in the pathophysiology and treatment of aplastic anemia. Hematol Am Soc Hematol Educ Program 2013:76\u201381. https:\/\/doi.org\/10.1182\/asheducation-2013.1.76","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"6460_CR6","doi-asserted-by":"crossref","unstructured":"Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM et al (1967) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53: 504\u2013514. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006-4971(20)74742-7","DOI":"10.1182\/blood.V53.3.504.504"},{"key":"6460_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1182\/blood.V62.4.883.883","volume":"62","author":"B Camitta","year":"1983","unstructured":"Camitta B, O\u2019Reilly RJ, Sensenbrenner L, Rappeport J, Champlin R, Doney K (1983) Antithoracic duct lymphocyte Globulin therapy of severe aplastic anemia. Blood 62:883\u2013888. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006-4971(20)85092-7","journal-title":"Blood"},{"key":"6460_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/nejmoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO et al (2011) Horse versus rabbit antithymocyte Globulin in acquired aplastic anemia. N Engl J Med 365:430\u2013438. https:\/\/doi.org\/10.1056\/nejmoa1103975","journal-title":"N Engl J Med"},{"key":"6460_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s12185-016-2053-8","volume":"104","author":"S Chuncharunee","year":"2016","unstructured":"Chuncharunee S, Wong R, Rojnuckarin P, Chang CS, Chang KM, Lu MY et al (2016) Efficacy of rabbit antithymocyte Globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. Int J Hematol 104:454\u2013461. https:\/\/doi.org\/10.1007\/s12185-016-2053-8","journal-title":"Int J Hematol"},{"key":"6460_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A et al (2016) Guidelines for the diagnosis and management of adult aplastic anemia. Br J Haematol 172:187\u2013207. https:\/\/doi.org\/10.1111\/bjh.13853","journal-title":"Br J Haematol"},{"key":"6460_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/bmt.2012.220","volume":"48","author":"B H\u00f6chsmann","year":"2013","unstructured":"H\u00f6chsmann B, Moicean A, Risitano A, Ljungman P, Schrezenmeier H, for the EBMT Working Party on Aplastic Anemia (2013) Supportive care in severe and very severe aplastic anemia. Bone Marrow Transpl 48:168\u2013173. https:\/\/doi.org\/10.1038\/bmt.2012.220","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"6460_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R Peffault de Latour","year":"2022","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M et al (2022) Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med 386(1):11\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2109965","journal-title":"N Engl J Med"},{"key":"6460_CR13","doi-asserted-by":"publisher","first-page":"101132","DOI":"10.1016\/j.blre.2023.101132","volume":"62","author":"A Bosi","year":"2023","unstructured":"Bosi A, Barcellini W, Passamonti F, Fattizzo B (2023) Androgen use in bone marrow failures and myeloid neoplasms: mechanisms of action and a systematic review of clinical data. Blood Rev 62:101132. https:\/\/doi.org\/10.1016\/j.blre.2023.101132","journal-title":"Blood Rev"},{"key":"6460_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3275\/6149","volume":"32","author":"S Shahani","year":"2009","unstructured":"Shahani S, Braga-Basaria M, Maggio M, Basaria S (2009) Androgens and erythropoiesis: past and present. J Endocrinol Invest 32:704\u2013716. https:\/\/doi.org\/10.3275\/6149","journal-title":"J Endocrinol Invest"},{"key":"6460_CR15","first-page":"251","volume":"27","author":"P Khemaphiphat","year":"2017","unstructured":"Khemaphiphat P, Thedsawad A, Jianthanakanon J, Taka O, Wanachiwanawin W (2017) Therapeutic response to immunosuppressive agents among Thai patients with Transplant-Ineligible aplastic anemia: possible predictive factors. J Hematol Transfus Med 27:251\u2013260. https:\/\/he01.tci-thaijo.org\/index.php\/JHematolTransfusMed\/article\/view\/71619\/78151","journal-title":"J Hematol Transfus Med"},{"key":"6460_CR16","doi-asserted-by":"publisher","first-page":"100181","DOI":"10.1016\/j.medidd.2024.100181","volume":"22","author":"T Somprasertkul","year":"2024","unstructured":"Somprasertkul T, Trirattanapikul W, Khamsai S, Chotmongkol V, Sawanyawisuth K (2024) Treatment response and its predictors of immunosuppressive therapy in patients with severe or very severe aplastic anemia. Med Drug Discov 22:100181. https:\/\/doi.org\/10.1016\/j.medidd.2024.100181","journal-title":"Med Drug Discov"},{"key":"6460_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3324\/haematol.2023.282935","volume":"109","author":"S Pagliuca","year":"2024","unstructured":"Pagliuca S, Kulasekararaj AG, Eikema DJ, Piepenbroek B, Iftikhar R, Satti TM et al (2024) Current use of androgens in bone marrow failure disorders: a report from the severe aplastic Anemia working party of the European society for blood and marrow transplantation. Haematologica 109:765\u2013776. https:\/\/doi.org\/10.3324\/haematol.2023.282935","journal-title":"Haematologica"},{"key":"6460_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00277-011-1163-x","volume":"90","author":"JC Jaime-P\u00e9rez","year":"2011","unstructured":"Jaime-P\u00e9rez JC, Colunga-Pedraza PR, G\u00f3mez-Ram\u00edrez CD, Guti\u00e9rrez-Aguirre CH, Cant\u00fa-Rodr\u00edguez OG, Tar\u00edn-Arzaga LC et al (2011) Danazol as first-line therapy for aplastic anemia. Ann Hematol 90:523\u2013527. https:\/\/doi.org\/10.1007\/s00277-011-1163-x","journal-title":"Ann Hematol"},{"key":"6460_CR19","doi-asserted-by":"publisher","first-page":"1135160","DOI":"10.3389\/fonc.2023.1135160","volume":"13","author":"M Nassani","year":"2023","unstructured":"Nassani M, El Fakih R, Passweg J, Cesaro S, Alzahrani H, Alahmari A et al (2023) The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes. Front Oncol 13:1135160. https:\/\/doi.org\/10.3389\/fonc.2023.1135160","journal-title":"Front Oncol"},{"key":"6460_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3324\/haematol.2023.283564","volume":"109","author":"RT Calado","year":"2024","unstructured":"Calado RT (2024) Bone marrow failure on steroids: when to use androgens? Haematologica 109:695\u2013697. https:\/\/doi.org\/10.3324\/haematol.2023.283564","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06460-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06460-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:29:46Z","timestamp":1757186986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06460-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6460"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06460-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Sakon Nakhon Hospital Ethical Committee. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration.After ethical committee approval, 111 patients were recruited after informed consent. No informed consent was required in 34 retrospectively reviewed cases according to our Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}